Motherhood, pair bonding and parental relatedness as modulators of epigenetic aging
Project Number3P20GM109091-10S4
Former Number5P20GM109091-10
Contact PI/Project LeaderKIARIS, HIPPOKRATIS Other PIs
Awardee OrganizationUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
Description
Abstract Text
Summary
Sex and gender differences in aging and other health outcomes are frequently severely confounded by
behavioral and environmental factors, mandating the use of animal models. Epigenetic age estimators provide
a powerful tool in determining the epigenetic age alleviating the necessity of monitoring cohorts of animals
throughout their lives in captivity or in the wild. The present study, by using outbred deer mice (Peromyscus)
will explore how genetic relatedness of parents, history of social interactions, and CDK8/19 inhibition impact
epigenetic age. The study relies on preliminary data indicating differences in the rate of epigenetic aging
between males and females upon these interventions. Mechanistically, to link genetic relatedness with aging
we will focus on the induction of endoplasmic reticulum (ER) stress, that reportedly differs between men and
women. For our studies both monogamous and polygamous Peromyscus will be used. Specifically, we will (a).
test if ER stress in females is more dependent on overall heterozygosity status than in males. Peromyscus
male and female offspring of parents that differ in their genetic relatedness, as well as fibroblasts cultured in
vitro, will be evaluated for ER stress and the resulting UPR, by analyzing the levels of a roster of chaperones
that reflect ER stress. For our analysis we will utilize animals from all different stocks of Peromyscus as well as
F1 hybrids between different stocks and species. (b). we will explore how the biobehavioral environment
impacts epigenetic age estimators. We propose to test how pair bonding, disruption and biparental care,
impact comparatively epigenetic aging in males and females, both the offspring as well as their parents. (c). we
will explore the impact of CDK8/19 inhibition in epigenetic aging. Pharmacological interventions aiming to
alleviate aging, besides providing avenues for the development of anti-aging therapies they also point to
disparities impacting differentially the different sexes. Preliminary findings in mice indicate that inhibition of
cyclin dependent kinases (CDK) 8/19, which regulate signal-induced transcription represents an avenue that
may hold significant anti-aging value, preferentially towards females. Here we propose to explore if CDK8/19
inhibition decreases the epigenetic age, and alleviates telomere attrition and mitochondrial abundance of
outbred deer mice. The proposed study constitutes a first effort to describe sex-based disparities in epigenetic
aging in relation socioenvironmental factors and choices that impact the women’s social environment in the
context of pair bonding and parents’ genetic relatedness. A. pharmacological intervention that prevents agent
preferably in women will also be evaluated.
Public Health Relevance Statement
Narrative
Epigenetic age estimators provide a powerful tool in determining epigenetic age, alleviating the
necessity of monitoring cohorts of animals throughout their lives in captivity or in the wild. Sex and gender
differences in aging and other health outcomes are frequently severely confounded by behavioral and
environmental factors, mandating the use of animal models. The present study, by using outbred deer mice
(Peromyscus) will explore how genetic relatedness of parents, history of social interactions, and CDK8/19
inhibition impact epigenetic age.
No Sub Projects information available for 3P20GM109091-10S4
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P20GM109091-10S4
Patents
No Patents information available for 3P20GM109091-10S4
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P20GM109091-10S4
Clinical Studies
No Clinical Studies information available for 3P20GM109091-10S4
News and More
Related News Releases
No news release information available for 3P20GM109091-10S4
History
No Historical information available for 3P20GM109091-10S4
Similar Projects
No Similar Projects information available for 3P20GM109091-10S4